Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease
Clinical trial NCT04277247 · UNKNOWN
Trial details
- NCT number
- NCT04277247
- Sponsor
- University of Calgary
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-12
- Primary completion
- 2022-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.